Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

Summary

The purpose of this study is to evaluate the efficacy, safety and immunogenicity of GX-19N in healthy individuals who have received one of COVID-19 vaccine authorized for emergency use.

Timeline

Start

2021-10

Primary completion

2022-10

Completion

2023-10

Outcome

Outcome not reported

Stopped (Business): “Change of development strategy in consideration of the global COVID-19 situation”

Drugs

Indications